2019 annual financial data
Enanta Pharmaceuticals 2019 Operating margin
Enanta Pharmaceuticals 2019 operating margin with verified reported values.
Direct answer
Operating margin was 17.9%.
Operating income was 36,738,000 USD and net income was 46,383,000 USD.
Operating cash flow was 71,418,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 205,197,000 USD
- Operating income
- 36,738,000 USD
- Net income
- 46,383,000 USD
- Operating cash flow
- 71,418,000 USD